JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aimond, F.
Right arrow Articles by Vassort, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aimond, F.
Right arrow Articles by Vassort, G.

Vol. 292, Issue 1, 415-424, January 2000

Cellular and In Vivo Electrophysiological Effects of Dronedarone in Normal and Postmyocardial Infarcted Rats

Frank Aimond1 , Lionel Beck1 , Patrick Gautier, Ouafiya K. Chérif, Jean-Marc Davy, Paco Lorente, Dino Nisato and Guy Vassort

Institut National de la Santé et de la Recherche Médicale, Physiopathologie Cardiovasculaire, CHU Arnaud de Villeneuve (F.A., L.B., O.K.C., P.L., G.V.), Montpellier ; Service de Cardiologie CHU Arnaud de Villeneuve (J.-M.D.), Montpellier; and Sanofi Recherches (P.G., D.N.), Montpellier, France

We studied the effects of dronedarone (SR 33589) on the action potentials, membrane ionic currents, and arrhythmic activity in control rats and in rats after myocardial infarction, a model known to develop anomalous electrical activity. Dronedarone increased action potential duration in normal hearts. It had little effect on the action potentials that were already prolonged in the postmyocardial infarcted (PMI) rats. Particularly, dronedarone reduced the late sustained K+ current, IK (or Isus) by 69%. Dronedarone induced only a tonic block of IK. Similar relative inhibitions of IK by dronedarone were obtained in young, sham, and PMI rats, even if IK was less in sham than in young and further reduced in PMI rats. The EC50 values were 0.78 and 0.85 µM in sham and PMI rats. Dronedarone induced a weak increase in the fast transient outward current, Ito. Time-to-peak and inactivation time constant of Ito were decreased by dronedarone that also induced a marked slowing of Ito recovery from inactivation. Similar effects were observed on the reduced Ito recorded in PMI rats. Holter monitoring study in control, unthetered animals showed that dronedarone had no proarrhythmic effect. On rats, which after myocardial infarction exhibited ventricular premature beats, dronedarone significantly decreased beat occurrence during the 7-day treatment; this effect was sustained for two more weeks. Thus, dronedarone exerts antiarrhythmic effects on PMI rat heart. Its effects are attributable for the most part to the inhibition of outward K+ currents and the increase in effective refractory period.


1 This work is part of the thesis of F.A. and L.B.


0022-3565/0/2921-0415$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
K. M Dale and C M. White
Dronedarone: An Amiodarone Analog for the Treatment of Atrial Fibrillation and Atrial Flutter
Ann. Pharmacother., April 1, 2007; 41(4): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. J. Tafreshi and J. Rowles
A Review of the Investigational Antiarrhythmic Agent Dronedarone
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 15 - 26.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
N. Wadhani, J. S. Sarma, B. N. Singh, D. Radzik, and C. Gaud
Dose-Dependent Effects of Oral Dronedarone on the Circadian Variation of RR and QT Intervals in Healthy Subjects: Implications for Antiarrhythmic Actions.
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 184 - 190.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Kirchhof, H. Degen, M. R. Franz, L. Eckardt, L. Fabritz, P. Milberg, S. Laer, J. Neumann, G. Breithardt, and W. Haverkamp
Amiodarone-Induced Postrepolarization Refractoriness Suppresses Induction of Ventricular Fibrillation
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 257 - 263.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
A. D Pitt, C. Fernandes, N. L Bewick, P. D Hemsworth, K. A Buhagiar, P. S Hansen, H. H Rasmussen, L. Delbridge, and D. W Whalley
Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedarone
Cardiovasc Res, January 1, 2003; 57(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh and J. S. M. Sarma
Mechanisms of Action of Antiarrhythmic Drugs Relative to the Origin and Perpetuation of Cardiac Arrhythmias
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 69 - 87.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.